Tsingke Introduces Validation Workflow for AI Designed Proteins
Beijing Tsingke Biotech Co., Ltd. introduced an integrated workflow for validating large libraries of proteins and antibodies designed with AI, the company said in a press release. The process combines gene synthesis, parallel expression, initial screening, larger scale production, purification and quantitative binding analysis.
The workflow starts with batch gene synthesis and parallel expression, followed by screening through methods such as ELISA binding assays. Selected candidates can proceed to purification, gram scale production and analysis with biolayer interferometry or surface plasmon resonance to measure KD, kon and koff.
Tsingke says the workflow can process up to 1,500 antibody candidates per day. For applicable projects, delivery from gene to antibody can take seven calendar days, plus five days for shipping. Supported antibody formats include scFv, VHH, Fab and full length IgG.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 12 Unio Health Partners deploys Basata's AI agents for patient intake across 60 specialty clinics Nov 12 LERA Health launches women's health platform with an AI coach for $29 a month Nov 12 DIAGENS releases CT model covering 509 chest and abdominal findings Nov 12 LateralCare signs six US hospital associations to offer its AI revenue cycle platform Nov 12 SmileFy launches AI Smile Designer that plans dental makeovers from a photo and scanLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
OpenAI Introduces BioBasicsBench for Wet Lab Analysis
Genedata Adds NVIDIA RFD4-Proteina to Biologics Discovery Workflows
BioMap Announces 11 AI Life Science Collaborations
MegaRobo Launches AI Protein Design Competition
Illumina Adds Three Research Tools to BioInsight Platform
Daily AI Brief: the AI news that matters, in your inbox.